Funded startups/Immuneering Corp

Immuneering Corp

SEC filing

Biotechnology · Cambridge, MA

Form D on EDGAR

Amount raised$25Msold at filing

Total offering$25M

Investors in the raise9count reported to the SEC

FiledSep 9, 2025first sale Aug 26, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Benjamin J. ZeskindExecutive Officer, Director

Laurie B. KeatingDirector

Robert J. CarpenterDirector

Thomas J. SchallDirector

Diana F. HausmanDirector

Peter J. FeinbergDirector

Executive officers, directors and promoters as listed on the Form D.